Dr. Shaf Keshavjee, The University Health Network, Toronto, ON

Ever since the first successful lung transplant was performed in Toronto in 1983, the field has continued to evolve. More and more patients with end stage lung disease now have lung transplantation as a life- saving option. Survival and quality of life outcomes of lung transplantation continue to improve. Advances in surgical techniques and postoperative patient care have made it possible to transplant sicker patients and extracorporeal lung support technologies have made successful bridge to lung transplantation a routine reality. Advances in donor lung evaluation, preservation and treatment with ex vivo lung perfusion have doubled the number of lung transplants performed. We are on a threshold of a revolutionary change in the field of transplantation – the era of “personalized medicine for the organ” and the ability to engineer “super-organs” to provide superior post-transplant outcomes.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • understand the current indications for lung transplantation;
  • appreciate current capabilities in lung preservation and bridge to lung transplantation with artificial lung technologies.; and
  • describe state of the art outcomes of lung transplantation as well as future directions.